Relmada Therapeutics logo
Relmada Therapeutics RLMD
$ 3.42 -2.01%

Quarterly report 2024-Q2
added 08-07-2024

report update icon

Relmada Therapeutics Financial Statements 2011-2024 | RLMD

Annual Financial Statements Relmada Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

162 M 71.4 M 360 M 510 M 53.8 M 15.7 M 9.78 M 22.3 M 72.1 M 37.4 M - - -

Shares

30.1 M 29.6 M 17.6 M 15.6 M 6.31 M 3.14 M 3.02 M 2.9 M 2.49 M 620 K - - -

Historical Prices

5.37 2.41 20.5 33.3 48.8 5.32 2.8 3.24 6 54.8 - - -

Net Income

-98.8 M -157 M -126 M -59.5 M -17.3 M -8.96 M -6.29 M -2.97 M -20.8 M -21.3 M -45 K -12.1 K -

Revenue

- - - - - - - - - - 5.13 K 7.94 K -

Cost of Revenue

- - - - - - - - - - 4.04 K 5.8 K -

Gross Profit

- - - - - - - - - - 1.09 K 2.14 K -

Operating Income

-104 M -161 M -126 M -60.8 M -15.1 M -6.92 M -7.22 M -16.2 M -17.1 M - -6.77 M -3.16 M -

Interest Expense

5.15 M 2.66 M 1.2 M 1.4 M 104 K -1.34 M 932 K 13.2 M 4.92 K - 220 K 27.7 K -

EBITDA

-104 M -161 M -126 M -60.8 M -12.7 M -6.91 M -7.13 M -16.2 M -17.1 M -29.7 M -44.8 K -11.3 K -

Operating Expenses

104 M 161 M 126 M 60.8 M 12.7 M 6.92 M 7.22 M 16.2 M 17.1 M 13 M 46.1 K 13.8 K -

General and Administrative Expenses

48.9 M 47.9 M 35.1 M 24.9 M 5.7 M 3.97 M 5.93 M 10 M 9.23 M 12.1 M 45.1 K 9.09 K -

All numbers in USD currency

Quarterly Income Statement Relmada Therapeutics

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

30.2 M 30.1 M 30.1 M 30.1 M 30.1 M 30.1 M 30.1 M 30.1 M 29.9 M 29.4 M 27.7 M 17.5 M 17.1 M 16.6 M 16.3 M 16 M 15.3 M 14.7 M 14.5 M 9.76 M 8.25 M 9.76 M 25.6 M 3.14 M 19.1 M 12.5 M 12.5 M 12.5 M 12.5 M 12 M 12 M 12 M 12 M 12 M 11.4 M 10.8 M 11.4 M 10.8 M 10.2 M 8.15 M 8.06 M 49.8 M 28.5 M 2.45 M 23.5 M 24 M 23.5 M 13.9 M 14.1 M 14 M - - - -

Net Income

-17.8 M -21.8 M - -22 M -25.3 M -26.3 M - -39.4 M -39.9 M -39.7 M - -42.6 M -26.6 M -22.2 M - -16.9 M -11.1 M -10.7 M - -3.67 M -4.12 M -3.67 M -7.13 M -3.38 M -7.13 M -3.38 M -1.43 M -982 K -1.43 M -982 K -1.03 M -1.64 M -1.03 M -1.64 M -2.46 M 4.66 M -2.46 M 4.66 M 5.46 M -29.8 M 5.46 M -29.8 M -5.17 M -1.57 M -13.2 K -14.4 K -9.02 K -3.42 K -942 - - -90 - -

Revenue

- - - - - - - -552 K 9.48 K -15 K - -513 K -176 K -52.8 K - -245 K - - - - - - - - - - - - - - - - - - - - - - - - - 682 1.85 K - 634 14.9 K 2.15 K 6.43 K 400 6.03 K - - - -

Cost of Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 685 1.69 K - 322 11.5 K 1.85 K 4.8 K 292 4.51 K - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -3 164 - 312 3.4 K 299 1.62 K 108 1.52 K - - - -

Operating Income

-18.8 M -23 M - -22.7 M -26 M -28.2 M - -38.7 M -45.5 M -38.3 M - -42.7 M -26.5 M -22.4 M - -17.2 M -12.8 M -9.97 M - -3.71 M -4.14 M -3.71 M -3.48 M -2.41 M -5.89 M -2.41 M -1.46 M -981 K -1.46 M -981 K -1.54 M -1.62 M -1.54 M -1.62 M -5.72 M -4.63 M -5.72 M -4.63 M -4.38 M -3.72 M -4.38 M -3.72 M -5.06 M -482 K -19.5 K -14.4 K -9.02 K -3.42 K -2.48 K -503 - - - -

Interest Expense

- - - 1.32 M 1.36 M 1.21 M - 828 K 387 K 330 K - 298 K 323 K 420 K - 363 K 404 K 408 K - 37.9 K - 15.9 K -140 K -650 K -790 K -652 K 29.2 K -830 28.4 K 301 K 506 K -24 K 506 K -24 K 1.17 K 1.64 K 2.81 K 125 1.1 K 3.27 K 1.1 K 3.27 K 112 K 67 K - 29.4 K - - - - - - - -

EBITDA

- - - - - - - -38.7 M -45.5 M -38.3 M - -42.7 M -26.5 M -22.4 M - -17.2 M -12.8 M -9.97 M - -3.71 M -4.13 M -3.71 M -3.48 M -2.41 M -5.89 M -2.41 M -1.46 M -980 K -1.46 M -980 K -1.54 M -1.6 M -1.49 M -1.6 M -5.72 M -4.63 M -5.72 M -4.63 M -4.38 M -3.72 M -4.38 M -3.72 M -5.06 M -482 K -19.5 K -14.4 K -9.02 K -3.42 K -2.48 K -503 - - - -

Operating Expenses

18.8 M 23 M - 22.7 M 26 M 28.2 M - 38.7 M 45.5 M 38.3 M - 42.7 M 26.5 M 22.4 M - 17.2 M 12.8 M 9.97 M - 3.71 M 4.14 M 3.71 M 3.48 M 2.41 M 5.89 M 2.41 M 1.46 M 981 K 1.46 M 981 K 1.54 M 1.62 M 1.54 M 1.62 M 5.72 M 4.63 M 5.72 M 4.63 M 4.38 M 3.72 M -4.38 M -3.72 M -5.06 M -482 K 19.8 K 14.5 K 9.32 K 5.05 K 2.59 K 2.02 K - - - -

General and Administrative Expenses

8.1 M 9.68 M - 12.2 M 12.3 M 12.3 M - 8.21 M 14.6 M 13.3 M - 8.66 M 9.13 M 8.38 M - 5.95 M 7.43 M 5.47 M - 1.82 M 1.07 M 1.82 M 2.22 M 990 K 3.21 M 990 K 1.31 M 815 K 1.31 M 815 K 1.28 M 1.25 M 1.28 M 1.25 M 3.6 M 1.76 M 3.6 M 1.76 M 2.29 M 3 M -2.29 M -3 M -789 K -207 K 19.8 K 14.5 K 9.01 K 992 2.59 K 878 - - - -

All numbers in USD currency